Effects of Pasteurella haemolytica A1 culture supernatant on mechanisms controlling bovine alveolar macrophage oxygen radical production.
Pasteurella haemolytica A1 culture supernatant containing leukotoxin, and modifiers of cyclic nucleotide and arachidonate metabolism, were evaluated for their ability to alter oxygen radical production by pulmonary alveolar macrophages obtained from seven Holstein calves. Calves were sedated, and underwent bronchoalveolar lavage to harvest macrophages, which were then incubated with culture supernatant and/or the drugs and toxins under study, and challenged with opsonized zymosan to induce oxygen radical generation. This was measured by a chemiluminescence technique. Pasteurella haemolytica A1 culture supernatant alone delayed the time to maximum oxygen radical production, although total production was increased. The cyclooxygenase inhibitor indomethacin and the phospholipase inhibitor p-bromophenacyl bromide significantly reduced maximum oxygen radical production, but their effects were diminished in the presence of culture supernatant. Although forskolin markedly inhibited oxygen radical generation, this effect was not altered by culture supernatant. Incubation of macrophages with pertussis toxin had no effect on oxygen radical production, while incubation with cholera toxin did inhibit production. This inhibitory effect was significantly lessened by concurrent incubation with P. haemolytica A1 culture supernatant.
Conlon
P D
PD
Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph.
Shewen
P E
PE
Donnelly
S F
SF
Burger
J P
JP
D000098:Acetophenones / Q000494:pharmacology; D000818:Animals; D001427:Bacterial Toxins / Q000276:immunology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002417:Cattle; D002478:Cells, Cultured; D002772:Cholera Toxin / Q000494:pharmacology; D005576:Colforsin / Q000494:pharmacology; D005098:Exotoxins / Q000276:immunology; D005609:Free Radicals; D007166:Immunosuppressive Agents / Q000276:immunology; D007213:Indomethacin / Q000494:pharmacology; D008264:Macrophages / Q000378:metabolism*; D008297:Male; D010100:Oxygen / Q000378:metabolism*; D010325:Pasteurella / Q000276:immunology*; D037342:Pertussis Toxin; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D000098:Acetophenones; D001427:Bacterial Toxins; D005098:Exotoxins; D005609:Free Radicals; D007166:Immunosuppressive Agents; D010566:Virulence Factors, Bordetella; C018579:leukotoxin; D005576:Colforsin; D002772:Cholera Toxin; D037342:Pertussis Toxin; C006821:4-bromophenacyl bromide; D010100:Oxygen; D007213:Indomethacin